🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
The study is an open label, non-randomized study designed to evaluate the d...
Status
Terminated
Location
Johns Hopkins University
Start Date
2019-11-15
Trial ID
NCT03619655
Treatments Being Tested
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
Advances in the biological characterization of AML can now make a proper es...
Status
Unknown
Location
Hospital La Fe
Start Date
2010-12
Trial ID
NCT01296178
Treatments Being Tested
This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokin...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-01-29
Trial ID
NCT07208149
Treatments Being Tested
The primary trial objective is to determine the efficacy of KPT-330 (seline...
Status
Completed
Location
UZ Leuven - Universitair Ziekenhuis Leuven
Start Date
2014-04-09
Trial ID
NCT02025985
Treatments Being Tested
To evaluate the pharmacokinetics (PK) of LPV/r with saquinavir in HIV-1 inf...
Status
Completed
Location
Chulalongkorn University Hospital, Department of Pediatrics
Start Date
2003-10
Trial ID
NCT00476359
Treatments Being Tested
This study is a Phase I/II trial of Tivantinib plus FOLFOX for the treatmen...
Status
Completed
Location
Yale University School of Medicine
Start Date
2012-07
Trial ID
NCT01611857
Treatments Being Tested